Pharmachem Laboratories Announces Key Appointments
Tim Bauer is now senior director, key account development, and Alexis Collins is manager of scientific affairs.
Pharmachem Laboratories announced two key staffing changes. Tim Bauer is now senior director, key account development, and Alexis Collins is manager of scientific affairs. Both are based out of Pharmachem’s Kearny, NJ, headquarters.
Bauer will focus on expanding the company’s business in food and beverages. He has more than 25 years of experience in the sale of specialty ingredients to the food and beverages industry. Most recently, he served as senior director of sales and business development for Robertet Flavors, and prior to that he was North American sales director for Cargill’s health and food technology division.
Collins, meanwhile, most recently served as research associate, new product development, for Healthy Directions. She will apprise the sales team about the science behind the company’s ingredients and their potential applications.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
